Clinical Trial Update: Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions [Phase 2]

View source ↗

Summary

Phase 2 trial update on the Sm14 vaccine assessing safety and immune response in adults from endemic regions for schistosomiasis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• sm14 vaccine (sm14)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Schistosomiasis | Phase 2 | Status: COMPLETED